Effect of clarithromycin on acute asthma exacerbations in children: an open randomized study
- PMID: 22433020
- DOI: 10.1111/j.1399-3038.2012.01280.x
Effect of clarithromycin on acute asthma exacerbations in children: an open randomized study
Abstract
Background: Asthma exacerbations are major contributors to asthma morbidity and rather difficult to treat. There is inconclusive evidence that macrolide antibiotics may have an effect on asthma exacerbations through their antibacterial and/or anti-inflammatory properties. The aim of the study was to evaluate the efficacy of clarithromycin on medium-term asthma activity when given as an add-on therapy in children with acute asthma.
Methods: This pilot, open-labeled, randomized, prospective study included 40 school-aged children, with intermittent or mild persistent asthma, presenting with an acute exacerbation. Children were randomized to receive 15 mg/kg of clarithromycin for 3 wk, in addition to their regular (GINA-guided) exacerbation treatment. The microbial trigger of exacerbations was assessed by serology and PCR. Children were followed up with diary cards for 12 wk; lung function was assessed at entry, 3, and 12 wk after the exacerbation.
Results: Children in the clarithromycin group had significantly more symptom-free days (78 ± 2 vs. 69 ± 6 days, p < 0.00001) and less total number of periods with loss of control (9 vs. 19, respectively, p = 0.013) during the follow-up period, compared to controls. Moreover, treated children presented reduced duration of the index episode (5.0 ± 1 vs. 7.5 ± 1 days, p < 0.00001). Lung function did not differ between groups.
Conclusions: When added to regular treatment, a 3-wk course of clarithromycin was associated with an increase in the number of symptom-free days, reductions in the number and severity of days with loss of control following index episode, and a decrease in the duration of the initial asthma exacerbation.
© 2012 John Wiley & Sons A/S.
Comment in
-
Clarithromycin in treatment of acute asthma exacerbations: principles of appropriate antibiotic use.Pediatr Allergy Immunol. 2012 Dec;23(8):792; author reply 792-3. doi: 10.1111/j.1399-3038.2012.01335.x. Epub 2012 Sep 18. Pediatr Allergy Immunol. 2012. PMID: 22984834 No abstract available.
Similar articles
-
Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.Allergy. 2005 Mar;60(3):309-16. doi: 10.1111/j.1398-9995.2004.00772.x. Allergy. 2005. PMID: 15679715 Clinical Trial.
-
Effectiveness of high repeated doses of inhaled budesonide or fluticasone in controlling acute asthma exacerbations in young children.J Asthma. 2008 Sep;45(7):561-7. doi: 10.1080/02770900802005251. J Asthma. 2008. PMID: 18773327 Clinical Trial.
-
Benefits of a school-based asthma treatment program in the absence of secondhand smoke exposure: results of a randomized clinical trial.Arch Pediatr Adolesc Med. 2004 May;158(5):460-7. doi: 10.1001/archpedi.158.5.460. Arch Pediatr Adolesc Med. 2004. PMID: 15123479 Clinical Trial.
-
[Diagnosis and treatment of acute asthma in adults].Rev Alerg Mex. 2009;56 Suppl 1:S37-48. Rev Alerg Mex. 2009. PMID: 20873052 Review. Spanish.
-
Mechanisms and Management of Asthma Exacerbations.Am J Respir Crit Care Med. 2019 Feb 15;199(4):423-432. doi: 10.1164/rccm.201810-1931CI. Am J Respir Crit Care Med. 2019. PMID: 30562041 Review.
Cited by
-
Effects of Macrolide Treatment during the Hospitalization of Children with Childhood Wheezing Disease: A Systematic Review and Meta-Analysis.J Clin Med. 2018 Nov 9;7(11):432. doi: 10.3390/jcm7110432. J Clin Med. 2018. PMID: 30423980 Free PMC article.
-
The effects of macrolides in children with reactive airway disease: a systematic review and meta-analysis of randomized controlled trials.Drug Des Devel Ther. 2018 Nov 8;12:3825-3845. doi: 10.2147/DDDT.S183527. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 30510399 Free PMC article.
-
Macrolides versus placebo for chronic asthma.Cochrane Database Syst Rev. 2021 Nov 22;11(11):CD002997. doi: 10.1002/14651858.CD002997.pub5. Cochrane Database Syst Rev. 2021. PMID: 34807989 Free PMC article. Review.
-
A host gene expression approach for identifying triggers of asthma exacerbations.PLoS One. 2019 Apr 8;14(4):e0214871. doi: 10.1371/journal.pone.0214871. eCollection 2019. PLoS One. 2019. PMID: 30958855 Free PMC article.
-
Recent advances on diagnosis and management of childhood asthma and food allergies.Ital J Pediatr. 2013 Dec 27;39:80. doi: 10.1186/1824-7288-39-80. Ital J Pediatr. 2013. PMID: 24373684 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical